Spring 2025
By Lori Dougherty
Photography by John Deputy
The 2024 Presidential Symposium in September was a fitting send-off for Laure H. Glimcher, MD, who stepped down as president and CEO of the Institute on October 1. The event explored a strategic priority of Glimcher’s tenure and a central focus since the Institute’s founding, “A Patient-First Approach to the Future of Cancer Care.” Supporters of The Dana-Farber Campaign met incoming President and CEO Benjamin L. Ebert, MD, PhD, and heard updates from Institute leaders on areas of great promise for patients, including next-generation therapies, cancer care equity, and Dana-Farber’s proposed future cancer hospital. Presidential historian and Pulitzer Prize-winning author Doris Kearns Goodwin shared her own experience of Dana-Farber’s patient-first approach when her late husband, Richard “Dick” N. Goodwin, was diagnosed with cancer in 2017. She was joined by Dick’s oncologist, Glenn Hanna, MD.